TRAF2 and pachyonychia congenita: indicated that TRAF2 regulated TRAIL-induced cell apoptosis through the c-Flip/Caspase-8 pathway, suggesting that TRAF2 might be a neoteric biomarker for predicting outcome in prostate cancer (PC) patients (25).